216 related articles for article (PubMed ID: 26957958)
1. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
[TBL] [Abstract][Full Text] [Related]
2. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
[TBL] [Abstract][Full Text] [Related]
4. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria.
Adekunle AE; Oladimeji AA; Temi AP; Adeseye AI; Akinyeye OA; Taiwo RH
Pan Afr Med J; 2011; 9():6. PubMed ID: 22145054
[TBL] [Abstract][Full Text] [Related]
5. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
[TBL] [Abstract][Full Text] [Related]
7. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
[TBL] [Abstract][Full Text] [Related]
9. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
11. Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East Nigeria.
Diwe CK; Okwara EC; Enwere OO; Azike JE; Nwaimo NC
Pan Afr Med J; 2013; 16():7. PubMed ID: 24570778
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.
Chandra N; Joshi N; Raju YS; Kumar A; Teja VD
Indian J Med Res; 2013 Dec; 138(6):950-4. PubMed ID: 24521641
[TBL] [Abstract][Full Text] [Related]
16. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria.
Oje OJ; Sule WF; Famurewa D
Viral Immunol; 2012 Dec; 25(6):448-55. PubMed ID: 23171358
[TBL] [Abstract][Full Text] [Related]
17. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
[TBL] [Abstract][Full Text] [Related]
18. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
